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 In recent decades and today, one of the most popular areas of drug 
research is the improvement of critical properties of active drugs. The two 
main goals of modern pharmaceutical technology research are to maximize 
the bioavailability of already well-proven active ingredients and to reduce 
adverse side effects and toxicity without altering the underlying 
mechanisms of action. In addition, in order to maximize efficacy, there is a 
need to develop new drug formulations that can be used in a targeted, 
spatially and temporally well-defined manner in different segments of the 
human body. The bioavailability of drugs is defined as the fraction of an 
administered drug that reaches the systemic circulation. This is mainly 
influenced by the solubility properties of the active ingredients. The 
slowest process of the drug’s journey through the body is absorption, which 
can be accelerated by improving the dissolution properties of the drug 
and/or creating new alternative routes of administration (e.g., dermal, 
pulmonary administration). Therefore, the improvement of dissolution 
properties is one of the most important tasks of pharmaceutical technology 
today, and many different methods have been developed to achieve this. 
These methods include for example, salt formation, various dispersion 
processes, nanosuspension, amorphization, and particle size reduction. The 
most promising of these are particle size reduction and amorphization, 
which can significantly increase the efficacy of drugs. A large group of 
active substances requiring such improvements are non-steroidal 
anti-inflammatory drugs (NSAIDs), as they are highly insoluble in 
water in their usual commercially available form. Innovative 
nanotechnology can be used to produce nanocomposite particles with 
specific (e.g., magnetic or pH-sensitive) properties, which can be used for 
targeted drug delivery and controlled release. Nanocomposite particles 
form the core of many modern medical diagnostic and therapeutic 
applications and are also the focus of attention in today’s research. The 
most commonly used magnetic nanoparticle is magnetite (Fe3O4) due to its 
high biocompatibility and superparamagnetic properties. The applicability 
of magnetic nanoparticles and nanocomposites is highly dependent on the 
size, shape and surface properties of the particles. [1,2] 
 For inorganic materials and simple polymers, amorphization and 
particle size reduction using lasers are already common practices. Using 
Pulsed Laser Ablation (PLA), we can reduce the particle diameter of 
certain materials down to the nanometer range. Furthermore, in recent 
years, inorganic nanocomposite particles have also been successfully 
produced using PLA. Pulsed laser deposition (PLD) can be used to produce 
thin films with specific physical properties (e.g. crystallinity) by carefully 
adjusting the experimental parameters. Lasers are one of the most preferred 
and most efficient tools in material processing and are widely used. Laser 
light can be considered a highly reliable, wear- and contact-free (sterile) 
“tool” that can produce much higher quality products much more 
economically than conventional machining methods. This is also true for 
the laser processing of organic and medical materials, where its greatest 
advantage is clearly its sterility. [3–5] 
2. Experimental methods 
 In my dissertation, I describe a series of applications of pulsed laser 
pharmaceutical technology in a gas medium. All applications were based 
on the PLA method, which was used to reduce the particle size of some of 
the poorly water-soluble drug substances (ibuprofen, meloxicam, niflumic 
acid) and to modify the crystal structure of ibuprofen. In addition, I 
prepared magnetic nanocomposites containing magnetite nanoparticles and 
drugs.  
 The essence of PLA is to focus the high-energy laser pulse on the 
surface of the target. Due to the energy absorbed, high temperatures are 
generated in the target and material is ejected from it in small explosions in 
the direction of the surface normal. The properties of the particles ejected 
during ablation and the crater created in the target are determined by the 
optical (absorption), thermodynamic, topological and mechanical properties 
of the irradiated material, as well as by the parameters of the laser beam 
(wavelength, pulse time, energy density). PLA has been very successful in 
a variety of applications, such as nanometer-precision material processing 
in industry, the creation of nanoparticles and nanocomposites, and the 
restoration of works of art. However, its most successful applications for 
humans have been found in medicine, as it provides the basis for many 
modern medical treatments, such as the treatment of cancer cells, kidney 
stone removal, and well-known eye correction surgeries. In my 
experiments, I irradiated drug tablets containing pure drug substance (or 
pure drug mixed with magnetite nano-powder) with three laser beams of 
different wavelengths (UV, visible and near-infrared). For UV irradiation I 
used a KrF excimer laser (LLG Twinamp, FWHM = 18 ns, λ = 248 nm, f = 
10 Hz), while for the other two wavelengths I used the first and second 
harmonics of a Nd: YAG laser (Quantel, FWHM = 6 ns, λ = 532 nm / 1064 
nm, f = 10 Hz). The tablets were prepared with a hydraulic press at a 
pressure of 175 MPa. During ablation, I varied the energy densities 
between 1.5 Jcm-2 and 15 Jcm-2, differently for each drug. The produced 
particles were transported and collected with the help of 0.3-2 l/min N2 gas 
flow. During the generation of nanocomposites, I also used an external 
magnetic field to study the magnetic properties of the resulting particles. 
The other method I use is PLD which is based on PLA. In PLD, not only 
the target is placed in the chamber, but a substrate is also placed in front of 
the target to collect the ablated particles. By varying the number of pulses 
hitting the target, a thin layer of virtually any thickness can be deposited on 
the substrate. PLD is usually performed under vacuum to increase 
efficiency. The great advantage of PLD is that by choosing the right laser 
parameters, it is possible to produce a thin layer of practically any material 
with good quality and arbitrary composition, while the process of layer 
building can be precisely controlled. Besides industrial applications, PLD is 
also used extensively in medical biology, where biocompatible coatings are 
made, and has recently shown promising results in the field of cell and 
tissue printing. Using KrF excimer laser (emitting in the UV range) , I 
managed to modify the crystal structure of ibuprofen by PLD. At different 
vacuum chamber pressures (1 - 10-4 mbar) the ablated particles were 
deposited on KBr substrates. I kept the energy density of the laser beam 
fixed at 3 Jcm-2 and created each thin layer with 10,000 pulses. The 
physical and chemical properties of the ablated drugs were investigated 
using different methods to make sure that the particles / thin films are 
suitable for the development of new drug formulations and for human 
testing. For this purpose, infrared and Raman spectroscopic measurements 
as well as scanning electron microscopy and energy dispersive X-ray 
spectroscopic studies were performed. Moreover, comprehensive size 
distribution studies were carried out on the produced particles in the range 
of 10 nm to 10 μm. In order to get an idea of the formation mechanism of 
the resulting particles, fast imaging was performed using a pump-probe 
setup. 
3. New scientific results 
In my thesis, I investigated the applicability of laser irradiation for 
the development of a new type of pharmaceutical formulation process. I 
conducted extensive experimental studies to see how the active ingredients 
respond to the adjustment of laser parameters and other experimental 
conditions. I have inspected whether the chemical composition and/or any 
physical parameters (particle diameter, crystallinity, morphology) of the 
drug change during laser ablation, as these are key properties for its future 
therapeutic use. I interpreted the experimental results based on theoretical 
considerations, and summarize my findings thematically in the following 
thesis points: 
3.1 Thesis points 
T1. Particle size reduction of non-steroidal anti-inflammatory drugs 
(NSAIDs) by pulsed laser ablation (PLA). 
Most NSAIDs have very low solubility in water. Therefore, to achieve the 
desired therapeutic effect, a relatively high intake of the drug is required, 
often leading to gastrointestinal complications. By reducing the particle 
size, the dissolution rate of the active substances can be increased, thus the 
amount of substance needed can be reduced and adverse side effects can be 
avoided. 
T1/A. I have shown that pulsed laser ablation can be successfully applied 
to reduce the particle size of poorly water-soluble drugs (e.g., ibuprofen, 
niflumic acid and meloxicam) by several orders of magnitude. Using laser 
beams of different wavelengths (532 nm; 1064 nm) and nanosecond pulse 
durations (6 ns for λ=532/1064 nm), nano- and submicrometer-sized drug 
particles could be prepared. Due to the increased surface-to-volume ratio of 
the resulting particles, the dissolution rate of the drugs has improved. 
T1/B. Using FTIR and Raman spectroscopy, I have shown that the 
chemical composition of the particles ablated by VIS and IR laser pulses is 
identical to that of the original active ingredients. I have also shown that 
ablation with ultraviolet laser beam results in chemically degraded drug 
particles. The chemical composition of the particles produced was 
independent of the energy density of the pulses in the investigated range 
(1.5-15 Jcm-2). 
T1/C. Particle size distribution studies over a wide size range (10 nm-10 
µm) have shown that the average size of the generated particles falls in the 
submicrometer regime depending on the specific drug and the wavelength 
of the applied laser beam. [S1] [S8] 
 
T2. Investigation of the drug particle formation mechanism during the 
ablation process. 
Considering the relatively high energy density of laser pulses and the 
sensitivity (e.g. thermal stability) of drug substances at the same time, it is a 
legitimate question to ask, what the ablation mechanism could be, by which 
the particle size is reduced without any chemical damage. Therefore, I have 
studied the laser ablation process in detail. 
T2/A. I have shown that the ejection of chemically intact drug particles is 
caused by secondary (photomechanical) processes during the ablation.  
T2/B. Ellipsometric studies were performed to determine the optical 
absorption of the drug tablets. Based on these data, temperature 
calculations were performed within the absorption volumes.  My results 
showed that the temperature in the absorption volume was higher than the 
decomposition temperature of the active pharmaceutical ingredient in all 
cases. Thus, the chemically non-degraded particles cannot originate from 
the primary processes of ablation. 
T2/C. To monitor the ablation processes over time, a typical pump-and-
probe setup was built. Using the recordings, I determined the velocity of 
the shock wave propagating outwards from the excited area and then, based 
on this, I calculated the recoil pressure exerted on the surface by the shock 
wave. The calculations revealed a significant recoil pressure (80-350 atm), 
indicating strong photomechanical effects responsible for the fracturing of 




T3. Preparation of amorphous and mixed (partly amorphous/partly 
crystalline) phase ibuprofen thin films by pulsed laser deposition 
(PLD). 
In addition to particle size reduction, amorphization is a well-known 
technique to increase the solubility and thus bioavailability of poorly 
soluble drugs. However, the production of amorphous phase often requires 
very complex procedures. Laser irradiation offers a relatively simple crystal 
engineering method for the production of amorphous phases of active 
pharmaceutical ingredients. 
T3/A. Amorphous and mixed phase ibuprofen thin films were prepared by 
PLD using a UV laser beam (λ=248 nm). I varied the pulse durations of 
laser beams (18 ns /500 fs) and the pressure applied in the experimental 
chamber (1 bar-10-4 mbar). 
T3/B. Infrared (FTIR) and Raman spectroscopy were used to determine the 
chemical composition and chemical homogeneity of the thin films. The 
material of the thin film produced with femtosecond pulses degraded, as 
did the one produced at atmospheric pressure. 
Using nanosecond laser pulses, ibuprofen thin films with mixed (crystalline 
and amorphous) aggregates were successfully produced at high chamber 
pressures (10-10-1 mbar), while purely amorphous thin films were produced 
at lower pressures (10-2-10-4 mbar). 
T3/C. The crystallinity of the layers was studied by Scanning electron 
microscopy (SEM)and differential scanning calorimetry (DSC). The results 
verified our observations described in the previous paragraph (i.e., the 
FTIR and Raman spectroscopy results were confirmed). [S2] [S7] 
 
T4. Production of magnetic drug nanocomposite particles by pulsed 
laser ablation. 
Magnetic drug nanocomposites can provide multifunctional theranostic 
platforms and allow for a combination of diagnostics, monitoring and 
therapeutics. Using magnetic nanocomposites for targeted delivery and 
controlled release of drugs, better treatment efficiency and less side effects 
can be achieved. 
T4/A. I was the first to apply PLA to produce magnetic drug 
nanocomposite particles. Using target tablets composed of commercially 
available ibuprofen (particle size ~5 µm) and magnetite nanoparticles 
(particle size ~50 nm), and applying Nd:YAG laser beams (532 and 1064 
nm), I successfully produced magnetic ibuprofen-magnetite composite 
nanoparticles. 
T4/B. Spectroscopic (FTIR, Raman, SEM-EDX) studies has shown, that 
the ablated particles contain both magnetite NPs and ibuprofen in its 
original chemical form (i.e., without any chemical degradation). 
T4/C. Particle size distributions obtained by SMPS revealed that some of 
the composite particles fall in the nanometer size range. It has also been 
found that the ibuprofen:magnetite ratio of the target and the wavelength of 
the laser have no significant effect on the size of the particles produced 
under the selected experimental conditions. 
T4/D. The experiments described in the previous paragraphs (T4/A-C) 
were repeated in the presence of an external magnetic field. Fast 
photography studies demonstrated that the two ingredients (magnetite and 
ibuprofen) definitely merge during PLA, and composite particles are 
formed. [S3] 
3.2 Additional point for thesis 
Although the next chapter does not belong to the thesis points of 
the dissertation, it plays an essential role in the completion of it. The 
studies presented here confirm the improved critical properties of PLA-
derived drug formulations compared to the reference materials.  
3.2.1. Investigation of the dissolution properties and bioavailability of 
NSAIDs prepared by PLA method 
Investigating the medical applicability of drug particles created by 
laser ablation, there is also a need for pharmaceutical technology 
measurements to provide information on the dissolution and toxicity 
properties of the new formulations. These measurements were carried out 
at the Institute of Pharmaceutical Technology and Pharmacovigilance of 
the University of Szeged. 
1/A. For all three drugs used, the dissolution rate and solubility of 
the ablated and reference materials were studied in aqueous solution at pH 
7.4 which is the typical pH of the gut and lungs. In all cases, the ablated 
particles showed higher dissolution rates than the starting materials. The 
solubility did not change significantly for ibuprofen and niflumic acid, 
while for meloxicam it doubled compared to the original value.  
1/B. The cytotoxicity measurements of the new formulations were 
performed on A549 cells modelling the alveolar wall of the lungs. Studies 
have shown that particles induced by laser ablation are suitable for 
pulmonary drug delivery. The ablated ibuprofen and meloxicam showed 
half the toxicity of the reference substances, which is an outstanding result, 
while in the case of niflumic acid the ablated substance was slightly more 
toxic than the original. The anti-inflammatory effect of the samples was 
also studied, where we found that all of the new formulations were more 
effective in reducing inflammation than commercially available pure active 
ingredients.  
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